• Alexander, M. (2018, February 14). Hypertension. In E. H. Yang (Ed.), Medscape. Retrieved from https://emedicine.medscape.com/article/241381-overview
• Alguire, P. C., & Mathes, B. M. (2017, December 4). Diagnostic evaluation of lower extremity chronic venous insufficiency. In K. A. Collins (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/diagnostic-evaluation-of-chronic-venous-insufficiency
• Alguire, P. C., & Scovell, S. (2018, May 29). Overview and management of lower extremity chronic venous disease. In K. A. Collins (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/overview-and-management-of-lower-extremity-chronic-venous-disease
• Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., . . . Page, R. L. (2018). 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Journal of the American College of Cardiology, 72(14), e91–e220. doi:10.1016/j.jacc.2017.10.054
• Alonso Salinas, G. L., Sanmartin, M., Pascual Izco, M., Rincon, L. M., Pueyo, P. P., del Castillo, A. M., . . . Azmorano, J. L. (2017, October). Frailty is an independent prognostic marker in elderly patients with myocardial infarction. Clinical Cardiology, 40(10), 925–931. doi:10.1002/clc.22749
• American Geriatrics Society 2015 Beers Criteria Update Expert Panel. (2015). American Geriatrics Society 2015 updated Beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatric Society, 63, 2227–2246. doi:10.1111/jgs.13702
• American Heart Association. (n.d.). Infective endocarditis. Retrieved from http://www.heart.org/HEARTORG/Conditions/CongenitalHeartDefects/TheImpactofCongenitalHeartDefects/Infective-Endocarditis_UCM_307108_Article.jsp
• Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Jr., Ganiats, T. G., Holmes, D. R., Jr., . . . Zieman, S. J. (2014, December). 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the America College of Cardiology, 64, e139–e228. doi:10.1016/j.jacc.2014.09.017
• Angeli, F., Verdecchia, P., Savonitto, S., Morici, N., De Servi, S., & Cavallini, C. (2014, April 1). Early invasive versus selectively invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: Impact of age. Catheterization and Cardiovascular Interventions, 83(5), 686–701. doi:10.1002/ccd.25307
• Armaganijan, L. V., Alexander, K. P., Huang, Z., Tricoci, P., Held, C., Van de Werf, F., . . . Lopes, R. D. (2016, August). Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. American Heart Journal, 178, 176–184. doi:10.1016/j.ahj.2016.05.012
• Barshes, N. (2017, November 22). Overview of upper extremity peripheral artery disease. In K. A. Collins (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/overview-of-upper-extremity-peripheral-artery-disease
• Bauer, K., & Lip, G. (2018, January). Overview of the causes of venous thrombosis. In G. Finlay (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/overview-of-the-causes-of-venous-thrombosis
• Benditt, D. (2018, June 2). Syncope in adults: Epidemiology, pathogenesis, and etiologies. In B. C. Downey (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/syncope-in-adults-epidemiology-pathogenesis-and-etiologies?
• Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., . . . Muntner, P. (2018). Heart disease and stroke statistics—2018 update: A report from the American Heart Association. Circulation, 137, e67–e492. doi:10.1161/CIR.0000000000000558
• Bibas, L., Levi, M., Touchette, J., Mardigyan, V., Bernier, M., Essebag, V., & Afilalo, J. (2016, June). Implications of frailty in elderly patients with electrophysiological conditions. JACC: Clinical Electrophysiology, 2(3), 288–294. doi:10.1016/j.jacep.2016.04.013
• Bueno, H. (2018). ACCA Clinical Decision-Making Toolkit, 2018 Edition: Instant guidance for diagnosis, risk management and treatment. Sophia Antipolis, France: European Society of Cardiology. Retrieved from https://www.escardio.org/Education/Practice-Tools/ACCA-Toolkit
• Carey, S. A., Cink, C., Hall, S., Kuiper, J., Hardaway, B., Theleman, K., . . . Sass, D. (2013). The impact of a comprehensive inpatient nurse practitioner led heart failure (HF) program. Journal of Cardiac Failure, 19(8 Suppl.), S90. doi:10.1016/j.cardfail.2013.06.287
• Centers for Disease Control and Prevention. (n.d.). Atrial fibrillation fact sheet. Retrieved from https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm
• Centers for Disease Control and Prevention. (n.d.). Peripheral arterial disease (PAD) fact sheet. Retrieved from https://www.cdc.gov/DHDSP/data_statistics/fact_sheets/fs_PAD.htm
• Centers for Disease Control and Prevention. (2017, September). Deep vein thrombosis (DVT). Retrieved from https://www.cdc.gov/healthcommunication/toolstemplates/entertainmented/tips/DeepVeinThrombosis.html
• CHA2DS2-VASc calculator for atrial fibrillation. (n.d.). ClinCalc.com. Retrieved from https://clincalc.com/cardiology/stroke/chadsvasc.aspx
• CHA2DS2-VASc/HAS-BLED/EHRA atrial fibrillation risk score calculator. (n.d.). Retrieved from https://www.chadsvasc.org
• Chen, J.-Y., Zhang, A.-D., Lu, H.-Y., Guo, J., Wang, F.-F., & Li, Z.-C. (2013, September). CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: A systematic review and meta-analysis. Journal of Geriatric Cardiology, 10(3), 258–266. doi:10.3969/j.issn.1671-5411.2013.03.004
• Chobanian, A. (2017, February 14). Hypertension in 2017—What is the right target? Journal of the American Medical Association, 317 (6), 579–580. doi:10.1001/jama.2017.0105
• Colucci, W. S. (2017, November 1). Drugs that should be avoided or used with caution in patients with heart failure. In S. B. Yeon (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/drugs-that-should-be-avoided-or-used-with-caution-in-patients-with-heart-failure
• Colucci, W. S. (2018, January 10). Evaluation of the patient with suspected heart failure. In S. B. Yeon (Ed.), UpToDate. Retrieved from http://www.uptodate.com/contents/evaluation-of-the-patient-with-suspected-heart-failure
• Di Nislo, M., van Es, N., & Büller, H. (2016, June). Deep vein thrombosis and pulmonary embolism. The Lancet, 388(10063), 3060–3073. doi:10.1016/S0140-6736(16)30514-1
• Denfeld, Q. E., Winters-Stone, K., Mudd, J. O., Gelow, J. M., Kurdi, S., & Lee, C. S. (2017, June 1). The prevalence of frailty in heart failure: A systematic review and meta-analysis. International Journal of Cardiology, 236, 283–289. doi:10.1016/j.ijcard.2017.01.153
• Drazner, M. (2018, September 21). Use of angiotensin receptorneprilysin inhibitor in heart failure with reduced ejection fraction. In S. B. Yeon (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/use-of-angiotensin-receptor-neprilysin-inhibitor-in-heart-failure-with-reduced-ejection-fraction
• Dumitru, I. (2018, May 7). Heart failure medication. In G. K. Sharma (Ed.), Medscape. Retrieved from https://emedicine.medscape.com/article/163062-medication
• Eberhardt, R., & Raffetto, J. (2014, July). Chronic venous insufficiency. Circulation, 130(4), 333–346. doi:10.1161/01.CIR.0000164199.72440.08
• Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., . . . Yanovsk, S. Z. (2013, November 12). 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation, 129(5 Suppl. 2), S76–S99. doi:10.1161/01.cir.0200437740.48606.d1
• Enomoto, Y., & Yoshimura, S. (2012). Antiplatelet therapy for carotid artery stenting. Interventional Neurology, 1(3–4), 151–163. doi:10.1159/000351686
• Executive Committee. (2016). The diagnosis and treatment of peripheral lymphedema: 2016 consensus of the International Society of Lymphology. Lymphology, 49(4), 170–184. Retrieved from
• https://www.internationalsocietyoflymphology.org/wp-content/uploads/2017/12/20106-35060-1-PB.pdf
• Fairman, R. (2016, October 19). Management of symptomatic carotid atherosclerotic disease. In J. F. Dashe & K. A. Collins (Eds.), UpToDate. Retrieved from https://www.uptodate.com/contents/management-of-symptomatic-carotid-atherosclerotic-disease
• Fairman, R. M. (2017, October 11). Management of asymptomatic carotid atherosclerotic disease. In J. F. Dashe & K. A. Collins (Eds.), UpToDate. Retrieved from https://www.uptodate.com/contents/management-of-asymptomatic-carotid-atherosclerotic-disease
• Fay, M., Fitzmaurice, D., & Freedman, B. (2017, October). Screening of older patients for atrial fibrillation in general practice: Current evidence and its implications for future practice. European Journal of General Practice, 23(1), 246–253. doi:10.1080/13814788.2017.1374366
• Furie, K. L. (2018, October 30). Pathophysiology of symptoms for carotid atherosclerosis. In J. F. Dashe (Eds.), UpToDate. Retrieved from https://www.uptodate.com/contents/pathophysiology-of-symptoms-from-carotid-atherosclerosis
• Ganz, L., & Spragg, D. (2018, March 12). Epidemiology of and risk factors for atrial fibrillation. In G. M. Saperia (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-atrial-fibrillation
• Gersh, B. (2017, October 17). Auscultation of heart sounds. In S. B. Yeon (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/auscultation-of-heart-sounds
• Go, A. S., Bauman, M., King, S. M. C., Fonarow, G. C., Lawrence, W., Williams, K. A., & Sanchez, E. (2014, April). An effective approach to high blood pressure control: A science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension, 63(4), 878–885. doi:10.1161/HYP.0000000000000003
• Goff, D. C., Jr., Lloyd-Jones, D. M., Bennett, G., Coady, S., D’Agostino, R. B., Gibbons, R., . . . Wilson, P. W. F. (2014). 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation, 129(25 Suppl. 2), S49–S73. doi:10.1161/01.cir.0000437741.48606.98
• Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Jr., Clark, L. T., Hunninghake, D. B., . . . Stone, N. J. (2008, October 30). Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110(2), 227–239. doi:10.1161/01.CIR.0000133317.49796.0E
• Gupta, K., & Shah, Z. (2015, June 16). What is the future of asymptomatic carotid artery disease? American College of Cardiology. Retrieved from http://www.acc.org/latest-in-cardiology/articles/2015/06/16/10/57/what-is-the-future-of-asymptomatic-carotid-artery-disease
• Gutierrez, C., & Blanchard, D. (2016, September). Diagnosis and treatment of atrial fibrillation. American Family Physician, 94(6), 442–452. Retrieved from https://www.aafp.org/afp/2016/0915/p442.html
• Heidenreich, P., Solis, P., Estes, N. A. M., III, Fonarow, G. C., Jurgens, C. Y., Marine, J. E., . . . McNamara, R. L. (2016, August). 2016 ACC/AHA clinical performance and quality measures for adults with atrial fibrillation or atrial flutter. Journal of the American College of Cardiology, 68(5), 525–568. doi:10.1016/j.jacc.2016.03.521
• James, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., . . . Ortiz, E. (2014). 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth Joint National Committee (JNC 8). Journal of the American Medical Association, 311(5), 507–520. doi:10.1001/jama.2013.284427
• Knecht, S., Petsch, S., & Studer, B. (2017, July). Atrial fibrillation in highrisk patients with ischaemic stroke. Lancet Neurology, 16 (7), 498. doi:10.1016/S1474-4422(17)30172-2
• Kumar, K. (2018, September 4). Overview of atrial fibrillation. In G. M. Saperia (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/overview-of-atrial-fibrillation
• Lab Tests Online. (2018). Retrieved from labtestsonline.org
• Lavigne, P. M., & Karas, R. H. (2013, January 29). The current state of niacin in cardiovascular disease prevention. Journal of the American College of Cardiology, 61, 440–446. doi:10.1016/j.jacc.2012.10.030
• Le Guen, J., Boumendil, A., Guidet, B., Corvol, A., Saint-Jean, O., & Somme, D. (2016, March). Are elderly patients’ opinions sought before admission to an intensive care unit? Results of the ICE-CUB study. Age and Ageing, 45(2), 303–309. doi:10.1093/ageing/afv191
• Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., . . . Zhao, D. X. (2016). 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Journal of the American College of Cardiology, 67, 1235–1250. doi:10.1016/j.jacc.2015.10.005
• Mann, J. F. E. (2018, September 19). Choice of drug therapy in primary (essential) hypertension. In J. P. Forman (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/choice-of-drug-therapy-in-primary-essential-hypertension
• McCarron, M. O., Goldstein, L. B., & Matchar, D. B. (2018, March 7). Screening for asymptomatic carotid artery stenosis. In J. F. Dashe (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/screening-for-asymptomatic-carotid-artery-stenosis
• Mitchell, E. (2018, January 30). Noninvasive diagnosis of arterial disease. In K. A. Collins (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/noninvasive-diagnosis-of-arterial-disease
• Morillo, C., Banerjee, A., Perel, P., Wood, D., & Jouven, X. (2017, March). Atrial fibrillation: The current epidemic. Journal of Geriatric Cardiology, 14(3), 195–203. doi:10.11909/j.issn.1671-5411.2017.03.011
• National Heart, Lung, and Blood Institute. (n.d.). DASH eating plan. Retrieved from https://www.nhlbi.nih.gov/health-topics/dash-eating-plan
• Nayor, M., & Vasan, R. S. (2016, May 3). Recent update to the US cholesterol treatment guidelines: A comparison with international guidelines. Circulation, 133(18), 1795–1806. doi:10.1161/CIRCULATIONAHA.116.021407
• Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., III., Fleisher, L. A., . . . Thompson, A. (2017, June 20). 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 135(25), e1159–e1195. doi:10.1161/CIR.0000000000000503
• O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Jr., Chung, M. K., de Lemos, J. A., . . . Zhao, D. X. (2013, January). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Journal of the American College of Cardiology, 61(4), e78–e140. doi:10.1016/j.jacc.2012.11.019
• Page, R. L., Joglar, J. A., Caldwell, M. A., Calkins, H., Conti, J. B., Deal, B. J., . . . Al-Khatib, S. M. (2016). 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology, 67 (13), e27–e115. doi:10.1016/j.jacc.2015.08.856
• Parks, A., & Fang, M. (2016, May). Anticoagulation in older adults with multimorbidity. Clinics in Geriatric Medicine, 32(2), 331–346. doi:10.1016/j.cger.2016.01.003
• Pignone, M. (2018, September 11). Management of elevated low density lipoprotein-cholesterol (LDL-C) in primary prevention of cardiovascular disease. In G. M. Saperia (Ed.), UpToDate. Retrieved from https://www.uptodate.com/contents/management-of-elevated-low-density-lipoprotein-cholesterol-ldl-c-in-primary-prevention-of-cardiovascular-disease
• Prescribers’ Digital Reference. (n.d.). Drug information. Retrieved from https://www.pdr.net/browse-by-drug-name